You Are Here: Home > About Arthritis > Arthritis in the News > Health Canada Approves Taltz® (ixekizumab) for Treatment of Active Psoriatic Arthritis

Health Canada Approves Taltz® (ixekizumab) for Treatment of Active Psoriatic Arthritis

Health Canada has officially approved Taltz® (ixekizumab) for the treatment of adults with active PsA. It can be used alone or in combination with a conventional DMARD, such as methotrexate.Back to News